2nd Oct 2008 16:39
Consort Medical plc
Confirmation of Board Appointment
Following a previous announcement made on 24 June 2008, Consort Medical plc confirms the appointment of Toby Woolrych as Group Finance Director with effect from 1 October 2008.
There are no further details requiring disclosure under Listing Rule 9.6.13.
For further information, please contact:
|
Consort Medical plc |
|
|
Jonathan Glenn, Chief Executive |
Tel: +44 (0) 1442 867920 |
|
Maitland |
|
|
Liz Morley |
Tel: +44 (0) 20 7379 5151 |
Consort Medical plc is a leader in medical devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals.
Consort Medical develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices, disposable facemasks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Hemel Hempstead in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and Mumbai, India. Consort Medical is a public company quoted on the full list of the London Stock Exchange (LSE: CSRT).
Related Shares:
CSRT.L